Concepedia

Manuel Tardáguila

MT

16

Publications

1.2K

Citations

15

H-Index

2013

Active since

Affiliations

Wellcome Sanger Institute(Current)

Centro Nacional de Biotecnología

University of Cambridge

Centro de Investigacion Principe Felipe

University of Florida

Manuel Tardáguila is an author at Wellcome Sanger Institute specializing in medicine, genetics, and gene expression.

ORCID

Top concepts

Publications per year

2013–2025

16

Publications

16

SQANTI: extensive characterization of long-read transcript sequences for quality control in full-length transcriptome identification and quantification

Manuel Tardáguila, Lorena de la Fuente, Cristina Martí et al. · Genome Research · 2018 · 474 citations · Full text

, , +22

CX3CL1 Promotes Breast Cancer via Transactivation of the EGF Pathway

Manuel Tardáguila, E. Mira, Miguel Ángel García‐Cabezas et al. · Cancer Research · 2013 · 98 citations · Full text

, , +14

Notch-regulated miR-223 targets the aryl hydrocarbon receptor pathway and increases cytokine production in macrophages from rheumatoid arthritis patients

Jesús Ogando, Manuel Tardáguila, Andrea Díaz-Alderete et al. · Scientific Reports · 2016 · 81 citations · Full text

SQANTI: extensive characterization of long read transcript sequences for quality control in full-length transcriptome identification and quantification

Manuel Tardáguila, Lorena de la Fuente, Cristina Martí et al. · 2017 · 74 citations · Full text

, , +22

Genetic perturbation of PU.1 binding and chromatin looping at neutrophil enhancers associates with autoimmune disease

Stephen M. Watt, Louella Vasquez, Klaudia Walter et al. · Nature Communications · 2021 · 72 citations · Full text

Rows per page

1–5 of 16